ArticleClinical case reports2025
Signet-Ring Cell Type Adenocarcinoma of the Urachus: A Rare Case.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Signet-Ring Cell Type Adenocarcinoma of the Urachus: A Rare Case.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urachal adenocarcinoma is a rare subset of bladder cancer originating from the urachus. We present a case of a 62-year-old woman with a 2-year history of persistent dysuria, urinary frequency, and urgency. On physical examination, a firm, non-tender suprapubic mass was detected. Cystoscopy was performed and a bladder mass was detected. After obtaining the biopsy, pathology confirmed a mucinous signet-ring cell type adenocarcinoma of urachal origin with negative margins and no vascular or perineural invasion. Following negative tumor markers, colonoscopy and CT scans for metastasis, the patient underwent partial cystectomy with tumor resection. No adjuvant therapy was administered. At 6-month follow-up, the patient was asymptomatic, and imaging showed no disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.